OpenSourceMalaria:Compound Series: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
Matthew Todd (talk | contribs) mNo edit summary |
Matthew Todd (talk | contribs) (Link to other possible series) |
||
| Line 18: | Line 18: | ||
[[OpenSourceMalaria:Other_GSK_Series_Under_Consideration |'''Other Possible GSK Series''']] | [[OpenSourceMalaria:Other_GSK_Series_Under_Consideration |'''Other Possible GSK Series''']] | ||
[[OpenSourceMalaria:Other Possible Series and Targets | '''Other Possible Series and Targets''']] | |||
[[OpenSourceMalaria:Epigenetic Regulation of Life Cycle | '''Epigenetic Regulation of Lifecycle''']] | [[OpenSourceMalaria:Epigenetic Regulation of Life Cycle | '''Epigenetic Regulation of Lifecycle''']] | ||
Revision as of 04:50, 5 May 2016
A summary of progress in the OSM project may be found in the Story so Far. The pages below include the technical detail of the individual series examined and are written for scientific contributors.
Series 1: GSK Arylpyrroles (being written up)
Series 2: GSK Triazoloureas (parked)
Series 3: GSK Thienopyrimidines (final compounds being made)
Series 4: Triazolopyrazines (TPs) (currently most active)
